Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma

Aaron S. Mansfield, Jun Vivien Yin, Penelope A. Bradbury, David J. Kwiatkowski, Shiven B. Patel, Lyudmila Bazhenova, Patrick M. Forde, Yanyan Lou, Paul Dizona, Liza C. Villaruz, Susanne M. Arnold, Maya Khalil, Hedy L. Kindler, Marianna Koczywas, J. A. de Freitas Pacheco, Christian Rolfo, Bing Xia, Elizabeth Mikula, Li Chen, Kashish Patel, Katherine E. Smith, Liang Cao, Geoffrey Shapiro, Brian A. Costello, Alex A. Adjei, Elad Sharon, Jeffrey A. Moscow, William C. Zamboni, Raffit Hassan